Christina Applegate discusses living with multiple sclerosis and why finishing her critically acclaimed show “Dead to Me” was important to her.
The actress, 50, spoke with the New York Times for an article published on Tuesday, ahead of the third and final season of her Netflix series, which will premiere later this month.
During the summer of 2021, Applegate reflected on what it was like to be diagnosed with MS. At the time, production was halted for approximately five months while she underwent treatment for an autoimmune disease that affects the central nervous system.
“There was the sense of, ‘Well, let’s get her some medicine so she can get better,’” Applegate said. “And there is no better. But it was good for me. I needed to process the loss of my life, my loss of that part of me. So I needed that time.”
The performer also noted that after that time, it wasn’t like she “came on the other side of it, like, ‘Woohoo, I’m totally fine.’ Acceptance? No. I’m never going to accept this. I’m pissed.”
She recalled how she first experienced balance and mobility issues during the production of the first season of “Dead to Me,” which premiered in May 2019.
“I wish I had paid attention,” she said. “But who was I to know?”
In light of her health news, Netflix considered canceling the show indefinitely during the production pause. However, Applegate felt she “had an obligation” to both “Dead to Me” creator Liz Feldman and her friend and costar Linda Cardellini, as well as the story.
“The powers that be were like, ‘Let’s just stop. We don’t need to finish it. Let’s put a few episodes together.’ I said, ‘No. We’re going to do it, but we’re going to do it on my terms,’” she said.
In addition to making sure the final season, Applegate felt it was important to promote “Dead to Me” ahead of the Season 3 premiere on Netflix on November 17.